Eplerenone
Products in Health Canada’s databases that list Eplerenone as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 10
- 8 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 10
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| INSPRA (25 MG) | 02323052 | Marketed | BGP Pharma ULC | |
| INSPRA (50 MG) | 02323060 | Marketed | BGP Pharma ULC | |
| JAMP EPLERENONE (25 MG) | 02543389 | Marketed | JAMP Pharma Corporation | |
| JAMP EPLERENONE (50 MG) | 02543397 | Marketed | JAMP Pharma Corporation | |
| MINT-EPLERENONE (25 MG) | 02471442 | Marketed | Mint Pharmaceuticals Inc | |
| MINT-EPLERENONE (50 MG) | 02471450 | Marketed | Mint Pharmaceuticals Inc | |
| APO-EPLERENONE (25 MG) | 02465019 | Approved | Apotex Inc. | |
| APO-EPLERENONE (50 MG) | 02465027 | Approved | Apotex Inc. | |
| GD-EPLERENONE (25 MG) | 02441543 | Cancelled Pre Market | Genmed A Division Of Pfizer Canada Ulc | |
| GD-EPLERENONE (50 MG) | 02441578 | Cancelled Pre Market | Genmed A Division Of Pfizer Canada Ulc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- JAMP EPLERENONENovember 30, 2023 · NOC 32220
- INSPRAJuly 6, 2023 · NOC 31135
- MINT-EPLERENONEApril 22, 2021 · NOC 25723
- INSPRAMay 13, 2020 · NOC 23596
- MINT-EPLERENONEJanuary 4, 2018 · NOC 20228
- GD-EPLERENONEAugust 28, 2017 · NOC 19724
- APO-EPLERENONEAugust 28, 2017 · NOC 19726
- INSPRAJune 12, 2014 · NOC 15715
- INSPRAAugust 30, 2012 · NOC 13607
- INSPRAFebruary 26, 2009 · NOC 10064